Birt-Hogg-Dubé Syndrome: Diagnosis and Management

Lancet Oncol. 2009 Dec;10(12):1199-206. doi: 10.1016/S1470-2045(09)70188-3.

Abstract

Birt-Hogg-Dubé syndrome (BHD) is an autosomal dominant condition characterised clinically by skin fibrofolliculomas, pulmonary cysts, spontaneous pneumothorax, and renal cancer. The condition is caused by germline mutations in the FLCN gene, which encodes folliculin; the function of this protein is largely unknown, although FLCN has been linked to the mTOR pathway. The availability of DNA-based diagnosis has allowed insight into the great variation in expression of FLCN, both within and between families. Patients can present with skin signs and also with pneumothorax or renal cancer. Preventive measures are aimed mainly at early diagnosis and treatment of renal cancer. This Review gives an overview of current diagnosis and management of BHD.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cysts / diagnosis
  • Cysts / genetics*
  • Cysts / therapy
  • Genetic Testing
  • Germ-Line Mutation*
  • Humans
  • Kidney Neoplasms / diagnosis
  • Kidney Neoplasms / genetics*
  • Kidney Neoplasms / therapy
  • Lung Diseases / diagnosis
  • Lung Diseases / genetics*
  • Lung Diseases / therapy
  • Pneumothorax / diagnosis
  • Pneumothorax / genetics*
  • Pneumothorax / therapy
  • Proto-Oncogene Proteins / genetics*
  • Skin Diseases / diagnosis
  • Skin Diseases / genetics*
  • Skin Diseases / therapy
  • Syndrome
  • Tumor Suppressor Proteins / genetics*

Substances

  • FLCN protein, human
  • Proto-Oncogene Proteins
  • Tumor Suppressor Proteins